J.W. Cole Advisors Inc. Boosts Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

J.W. Cole Advisors Inc. raised its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 25.5% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 3,785 shares of the company’s stock after acquiring an additional 768 shares during the period. J.W. Cole Advisors Inc.’s holdings in GE HealthCare Technologies were worth $296,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. LGT Financial Advisors LLC grew its stake in GE HealthCare Technologies by 1,673.3% during the third quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock valued at $25,000 after acquiring an additional 251 shares in the last quarter. Capital Performance Advisors LLP bought a new position in shares of GE HealthCare Technologies during the 3rd quarter valued at about $26,000. Ashton Thomas Securities LLC purchased a new position in shares of GE HealthCare Technologies during the third quarter valued at about $26,000. Darwin Wealth Management LLC bought a new stake in shares of GE HealthCare Technologies in the third quarter worth about $31,000. Finally, Continuum Advisory LLC lifted its position in shares of GE HealthCare Technologies by 101.8% in the third quarter. Continuum Advisory LLC now owns 333 shares of the company’s stock worth $31,000 after buying an additional 168 shares in the last quarter. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Down 0.5 %

Shares of GEHC opened at $92.09 on Friday. GE HealthCare Technologies Inc. has a twelve month low of $74.51 and a twelve month high of $94.80. The company has a current ratio of 1.04, a quick ratio of 0.83 and a debt-to-equity ratio of 0.88. The company’s fifty day simple moving average is $84.85 and its 200-day simple moving average is $85.76. The company has a market cap of $42.11 billion, a P/E ratio of 21.27, a P/E/G ratio of 3.21 and a beta of 1.15.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, topping analysts’ consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The company had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.33 billion. As a group, analysts expect that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

Analyst Ratings Changes

Several research firms have weighed in on GEHC. Citigroup raised their price target on GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a report on Thursday, February 13th. Jefferies Financial Group raised shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and raised their target price for the company from $95.00 to $103.00 in a report on Wednesday, January 8th. Finally, Wells Fargo & Company upped their price target on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the company an “overweight” rating in a research note on Friday, February 14th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, GE HealthCare Technologies has a consensus rating of “Moderate Buy” and a consensus price target of $97.67.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.